TVTX vs. NVT
TVTX (Travere Therapeutics, Inc.) and NVT (nVent Electric plc) are both stocks. TVTX operates in Biotechnology (Healthcare), while NVT operates in Electrical Equipment & Parts (Industrials). Over the past 5 years, TVTX returned 32.38%/yr vs 39.10%/yr for NVT. Their 0.26 correlation means their historical movements had little consistent relationship.
Performance
TVTX vs. NVT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TVTX achieves a 46.27% return, which is significantly lower than NVT's 51.57% return.
TVTX
- 1D
- -2.43%
- 1M
- -0.80%
- 6M
- 79.77%
- YTD
- 46.27%
- 1Y
- 261.75%
- 3Y*
- 49.52%
- 5Y*
- 32.38%
- 10Y*
- 11.81%
- ALL TIME*
- 30.16%
NVT
- 1D
- 6.24%
- 1M
- -3.72%
- 6M
- 37.41%
- YTD
- 51.57%
- 1Y
- 97.47%
- 3Y*
- 42.62%
- 5Y*
- 39.10%
- 10Y*
- —
- ALL TIME*
- 29.74%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $373.02M | $340.45M | $350.68M | |
| $68.60M | $72.66M | $103.44M |
TVTX vs. NVT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
TVTX Travere Therapeutics, Inc. | 46.27% | 119.35% | 93.77% | -57.25% | -32.25% | 13.89% | 91.94% | -37.25% | -9.84% |
NVT nVent Electric plc | 51.57% | 51.27% | 16.63% | 55.98% | 3.32% | 67.15% | -5.68% | 17.24% | 7.52% |
Correlation
The correlation between TVTX and NVT is 0.32, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.32 |
Correlation (3Y) Balances recent behavior with more history. | 0.26 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.25 |
Correlation (All Time) Calculated using the full available price history since May 1, 2018 | 0.26 |
Fundamentals
TVTX:
$5.20B
NVT:
$24.88B
TVTX:
-$0.49
NVT:
$3.63
TVTX:
9.89
NVT:
5.23
TVTX:
52.01
NVT:
6.33
TVTX:
$536.20M
NVT:
$4.83B
TVTX:
$385.20M
NVT:
$1.79B
TVTX:
$11.15M
NVT:
$1.01B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TVTX vs. NVT — Risk / Return Rank
TVTX
NVT
TVTX vs. NVT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Travere Therapeutics, Inc. (TVTX) and nVent Electric plc (NVT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| TVTX | NVT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.58 | ||
| Sortino ratioReturn per unit of downside risk | +1.72 | ||
| Omega ratioGain probability vs. loss probability | 1.56 | 1.34 | +0.22 |
| Calmar ratioReturn relative to maximum drawdown | 7.87 | 3.57 | +4.30 |
| Martin ratioReturn relative to average drawdown | 18.26 | 13.66 | +4.60 |
Loading charts...
Drawdowns
TVTX vs. NVT - Drawdown Comparison
The maximum TVTX drawdown since its inception was -85.43%, which is greater than NVT's maximum drawdown of -56.18%. Use the drawdown chart below to compare losses from any high point for TVTX and NVT.
Loading charts...
Drawdown Indicators
| TVTX | NVT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -85.43% | -56.18% | -29.25% |
Max Drawdown (1Y)Largest decline over 1 year | -33.49% | -27.42% | -6.07% |
Max Drawdown (3Y)Largest decline over 3 years | -68.35% | -46.67% | -21.68% |
Max Drawdown (5Y)Largest decline over 5 years | -83.12% | -46.67% | -36.45% |
Max Drawdown (10Y)Largest decline over 10 years | -83.64% | — | — |
Current DrawdownCurrent decline from peak | -5.32% | -16.44% | +11.12% |
Average DrawdownAverage peak-to-trough decline | -40.70% | -11.83% | -28.87% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 14.40% | 7.16% | +7.24% |
Volatility
TVTX vs. NVT - Volatility Comparison
The current volatility for Travere Therapeutics, Inc. (TVTX) is 7.92%, while nVent Electric plc (NVT) has a volatility of 16.96%. This indicates that TVTX experiences smaller price fluctuations and is considered to be less risky than NVT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| TVTX | NVT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.92% | 16.96% | -9.04% |
Volatility (6M)Calculated over the trailing 6-month period | 46.64% | 36.03% | +10.61% |
Volatility (1Y)Calculated over the trailing 1-year period | 71.03% | 45.95% | +25.08% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 66.25% | 37.09% | +29.16% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 58.32% | 38.93% | +19.39% |
Dividends
TVTX vs. NVT - Dividend Comparison
TVTX has not paid dividends to shareholders, while NVT's dividend yield for the trailing twelve months is around 0.54%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
NVT nVent Electric plc | 0.54% | 0.78% | 1.12% | 1.18% | 1.82% | 1.84% | 3.01% | 2.74% | 1.56% |
TVTX Travere Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
TVTX vs. NVT - Financials Comparison
This section allows you to compare key financial metrics between Travere Therapeutics, Inc. and nVent Electric plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
TVTX vs. NVT - Profitability Comparison
TVTX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Travere Therapeutics, Inc. reported a gross profit of 0.00 and revenue of 127.20M. Therefore, the gross margin over that period was 0.0%.
NVT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, nVent Electric plc reported a gross profit of 558.00M and revenue of 1.47B. Therefore, the gross margin over that period was 37.9%.
TVTX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Travere Therapeutics, Inc. reported an operating income of -36.60M and revenue of 127.20M, resulting in an operating margin of -28.8%.
NVT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, nVent Electric plc reported an operating income of 300.70M and revenue of 1.47B, resulting in an operating margin of 20.4%.
TVTX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Travere Therapeutics, Inc. reported a net income of -37.10M and revenue of 127.20M, resulting in a net margin of -29.2%.
NVT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, nVent Electric plc reported a net income of 215.90M and revenue of 1.47B, resulting in a net margin of 14.7%.
Frequently Asked Questions
TVTX and NVT have a correlation of 0.32, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NVT has higher volatility (16.96%) compared to TVTX (7.92%). In terms of maximum drawdown, TVTX dropped -85.43% vs NVT's -56.18%.
TVTX currently has the higher Sharpe Ratio (3.71 vs 2.13), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for TVTX and NVT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer